Li Enya, Brennan Caroline K, Ramirez Aaron, Tucker Jo A, Butkovich Nina, Meli Vijaykumar S, Ionkina Anastasia A, Nelson Edward L, Prescher Jennifer A, Wang Szu-Wen
Department of Chemical & Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.
Department of Chemistry, University of California, Irvine, CA, 92697, USA.
Mater Today Bio. 2022 Oct 8;17:100455. doi: 10.1016/j.mtbio.2022.100455. eCollection 2022 Dec 15.
Bioluminescence imaging has advantages over fluorescence imaging, such as minimal photobleaching and autofluorescence, and greater signal-to-noise ratios in many complex environments. Although significant achievements have been made in luciferase engineering for generating bright and stable reporters, the full capability of luciferases for nanoparticle tracking has not been comprehensively examined. In biocatalysis, enhanced enzyme performance after immobilization on nanoparticles has been reported. Thus, we hypothesized that by assembling luciferases onto a nanoparticle, the resulting complex could lead to substantially improved imaging properties. Using a modular bioconjugation strategy, we attached NanoLuc (NLuc) or Akaluc bioluminescent proteins to a protein nanoparticle platform (E2), yielding nanoparticles NLuc-E2 and Akaluc-E2, both with diameters of ∼45 nm. Although no significant differences were observed between different conditions involving Akaluc and Akaluc-E2, free NLuc at pH 5.0 showed significantly lower emission values than free NLuc at pH 7.4. Interestingly, NLuc immobilization on E2 nanoparticles (NLuc-E2) emitted increased luminescence at pH 7.4, and at pH 5.0 showed over two orders of magnitude (>200-fold) higher luminescence (than free NLuc), expanding the potential for imaging detection using the nanoparticle even upon endocytic uptake. After uptake by macrophages, the resulting luminescence with NLuc-E2 nanoparticles was up to 7-fold higher than with free NLuc at 48 h. Cells incubated with NLuc-E2 could also be imaged using live bioluminescence microscopy. Finally, biodistribution of nanoparticles into lymph nodes was detected through imaging using NLuc-E2, but not with conventionally-labeled fluorescent E2. Our data demonstrate that NLuc-bound nanoparticles have advantageous properties that can be utilized in applications ranging from single-cell imaging to biodistribution.
生物发光成像相对于荧光成像具有诸多优势,比如光漂白和自发荧光极小,并且在许多复杂环境中具有更高的信噪比。尽管在萤光素酶工程领域已取得显著成就,可生成明亮且稳定的报告基因,但萤光素酶在纳米颗粒追踪方面的全部能力尚未得到全面研究。在生物催化中,已有报道称将酶固定在纳米颗粒上后其性能会增强。因此,我们推测通过将萤光素酶组装到纳米颗粒上,所形成的复合物可能会带来显著改善的成像特性。我们采用模块化生物偶联策略,将纳米荧光素酶(NLuc)或Akaluc生物发光蛋白连接到蛋白质纳米颗粒平台(E2)上,得到直径约为45纳米的纳米颗粒NLuc-E2和Akaluc-E2。尽管在涉及Akaluc和Akaluc-E2的不同条件之间未观察到显著差异,但pH值为5.0时的游离NLuc发射值明显低于pH值为7.4时的游离NLuc。有趣的是,NLuc固定在E2纳米颗粒(NLuc-E2)上在pH值为7.4时发光增强,而在pH值为5.0时发光比游离NLuc高出两个数量级以上(>200倍),这扩大了即使在被内吞摄取后使用该纳米颗粒进行成像检测的潜力。巨噬细胞摄取后,在48小时时NLuc-E2纳米颗粒产生的发光比游离NLuc高出多达7倍。用NLuc-E2孵育的细胞也可以使用实时生物发光显微镜进行成像。最后,通过使用NLuc-E2成像检测到纳米颗粒在淋巴结中的生物分布,但使用传统标记的荧光E2则无法检测到。我们的数据表明,结合NLuc的纳米颗粒具有可用于从单细胞成像到生物分布等各种应用的有利特性。